2015-2025 Global RNAi for Therapeutic Market Research by Type, End-Use and Region (COVID-19 Version)

2023-2032 Global RNAi for Therapeutic Market Research by Type, End-Use and Region (COVID-19 Version)


Published on: 2024 Dec 16  |  No of Pages : 105  |  Industry : Medical Devices
Publisher : 99Strategy  |  Format : Electronics PDF

Summary

RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
The global RNAi for Therapeutic market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.

Further key aspects of the report indicate that:
Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
Chapter 2: Global Production & Consumption Market by Type and End-Use
Chapter 3: Europe Production & Consumption Market by Type and End-Use
Chapter 4: America Production & Consumption Market by Type and End-Use
Chapter 5: Asia Production & Consumption Market by Type and End-Use
Chapter 6: Oceania Production & Consumption Market by Type and End-Use
Chapter 7: Africa Production & Consumption Market by Type and End-Use
Chapter 8: Global Market Forecast by Type, End-Use and Region
Chapter 9: Company information, Sales, Cost, Margin, news etc.
Chapter 10: Market Competition by Companies and Market Concentration Ratio
Chapter 11: Market Impact by Coronavirus.
Chapter 12: Industry Summary
.
Market Segment as follows:

Market Segment By Key Companies:
Alnylam Pharmaceuticals
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
miRagen Therapeutics
Gradalis
Sirnaomics

Market Segment By Type:
siRNA
miRNA
shRNA

Market Segment By Application:
Cancer
Cardiovascular
HBV
Others

This report can be dispatched within 24-48 Hours.




Our Clients


electronic and semiconductor      SELENIS       electronic and semiconductor      electronic and semiconductor      electronic and semiconductor      electronic and semiconductor      electronic and semiconductor      electronic and semiconductor       mips protection       Opulent International       SELENIS       inkuy       MIVV      GSPANN      ANI CO., LTD      C2C      C2C      C2C      C2C      C2C

Our Services



customer service

Service Guarantee

All research reports have been offered with, post assessing the demands of our clients only.

service guarantee

24*7 Service

Our valued client, we offer 24/7 service(Monday-Friday), email assistance on Saturdays and Sundays.

service flexibility

Service Flexibility

Considering the implicit nature of market research, flexibility concerning services holds a remarkable position in our operations.

safe

Safe and Secure

Your payment details are safe and secured by us.



//